Q&A with Beckley Psytech CEO Cosmo Feilding Mellen
‘The combination of the drug and psychotherapy is critical. What will be interesting to see is how the healthcare infrastructure reacts to that. That will vary around the world because different healthcare systems are set up differently and mental ... Read More
“Unlocking the therapeutic potential of psychedelic medicine is not just a business for us, it is ...
Expert interview with Cosmo Feilding-Mellen on Beckley Psytech’s longstanding involvement in the psychedelic medicine space and best-in-class drug development team.
“The logic behind setting up Beckley Psytech was that there’s this body of evidence that’s been generated in an academic setting, in early stage, proof of concept settings. Now the next step is to actually take these drugs through the drug deve... Read More
Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding. Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to op... Read More